These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24229356)

  • 1. High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells.
    Sirenko O; Hesley J; Rusyn I; Cromwell EF
    Assay Drug Dev Technol; 2014; 12(1):43-54. PubMed ID: 24229356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Shinozawa T; Kimura M; Cai Y; Saiki N; Yoneyama Y; Ouchi R; Koike H; Maezawa M; Zhang RR; Dunn A; Ferguson A; Togo S; Lewis K; Thompson WL; Asai A; Takebe T
    Gastroenterology; 2021 Feb; 160(3):831-846.e10. PubMed ID: 33039464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis.
    Trask OJ; Moore A; LeCluyse EL
    Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes.
    Kim JH; Wang M; Lee J; Park HJ; Han C; Hong HS; Kim JS; An GH; Park K; Park HK; Zhu SF; Sun XB; Kim JH; Woo DH
    Cell Biol Toxicol; 2018 Feb; 34(1):51-64. PubMed ID: 28382404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
    Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
    Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Hepatotoxicity in iPSC-Derived Hepatocytes by Multiplexed High Content Assays.
    Sirenko O; Cromwell EF
    Methods Mol Biol; 2018; 1683():339-354. PubMed ID: 29082501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling.
    Hussain F; Basu S; Heng JJH; Loo LH; Zink D
    Arch Toxicol; 2020 Aug; 94(8):2749-2767. PubMed ID: 32533217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
    Donato MT; Tolosa L
    Differentiation; 2019; 106():15-22. PubMed ID: 30844688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative DNA damage contributes to usnic acid-induced toxicity in human induced pluripotent stem cell-derived hepatocytes.
    Gao X; Campasino K; Yourick MR; Cao Y; Yourick JJ; Sprando RL
    J Appl Toxicol; 2024 Sep; 44(9):1329-1346. PubMed ID: 38724177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
    Goldring C; Antoine DJ; Bonner F; Crozier J; Denning C; Fontana RJ; Hanley NA; Hay DC; Ingelman-Sundberg M; Juhila S; Kitteringham N; Silva-Lima B; Norris A; Pridgeon C; Ross JA; Young RS; Tagle D; Tornesi B; van de Water B; Weaver RJ; Zhang F; Park BK
    Hepatology; 2017 Feb; 65(2):710-721. PubMed ID: 27775817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.
    Schofield CA; Walker TM; Taylor MA; Patel M; Vlachou DF; Macina JM; Vidgeon-Hart MP; Williams A; McGill PJ; Newman CF; Sakatis MZ
    Chem Res Toxicol; 2021 Dec; 34(12):2485-2499. PubMed ID: 34797640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing high-fidelity hepatotoxicity models from pluripotent stem cells.
    Medine CN; Lucendo-Villarin B; Storck C; Wang F; Szkolnicka D; Khan F; Pernagallo S; Black JR; Marriage HM; Ross JA; Bradley M; Iredale JP; Flint O; Hay DC
    Stem Cells Transl Med; 2013 Jul; 2(7):505-9. PubMed ID: 23757504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.